Blog

Aaron Goodman: Saw dasatinib-induced hyperthyroidism in one of my patients and was unaware this could happen

Photo from Aaron Goodman/X

Feb 28, 2024, 12:20

Aaron Goodman: Saw dasatinib-induced hyperthyroidism in one of my patients and was unaware this could happen

Aaron Goodman recently shared a post on X/Twitter:

“Saw dasatinib-induced hyperthyroidism in one of my patients and was unaware this could happen. Here it is described with other thyroid abnormalities with second-generation Tyrosine kinase inhibitors (TKIs).”

Read further.

Source: Aaron Goodman/X

Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.

Aaron Goodman cancer Dasatinib dasatinib-induced hyperthyroidism National Comprehensive Cancer Network NHLs OncoDaily Oncology Tyrosine kinase inhibitors University of California San Diego

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage